September 18, 2017
- Guidance for Industry: International Council for Harmonization - Quality
- Q4B: Annex I: Residue on Ignition/Sulphated Ash General Chapter (PDF - 58KB)
- Q4B: Annex 2: Test for Extractable Volume of Parenteral Preparations General Chapter (PDF - 69KB)
- Q4B: Annex 3: Test for Particulate Contamination: Subvisible Particles General Chapter (PDF - 993KB)
- Q4B: Annex 4A: Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter (PDF - 69KB)
- Q4B: Annex 4B: Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-organisms General Chapter (PDF - 69KB)
- Q4B: Annex 4C: Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter (PDF - 57KB)
- Q4B: Annex 5: Disintegration Test General Chapter (PDF - 69KB)
- Q4B: Annex 8: Sterility Test General Chapter (PDF - 68KB)
- Q4B: Annex 9: Tablet Friability General Chapter (PDF - 68KB)
- Q4B: Annex 10: Polyacrylamide Gel Electrophoresis General Chapter (PDF - 57KB)
- ~Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- National Drug Code Directory (updated)
- Opportunities to Engage with the FDA About Qualification During Biomarker Development (PDF - 1.06MB)
- The Biomarker Qualification Process: A Roadmap for Requestors (PDF - 719KB)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
September 15, 2017
- FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia - Podcast
- FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia - Transcript
- The Biomarker Qualification Process: A Roadmap for Requesters – Podcast
- The Biomarker Qualification Process: A Roadmap for Requesters – Transcript
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Shortages
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
September 14, 2017
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Aliqopa (copanlisib), a new treatment for adults with relapsed follicular lymphoma
- FDA approves Mvasi (bevacizumab-awwb), a biosimilar to the cancer drug Avastin, for certain colorectal, lung, brain, kidney and cervical cancers
- FDA Drug Safety Podcast: FDA recommends separating dosing of potassium-lowering drug sodium polystyrene sulfonate (Kayexalate) from all other oral drugs
- FDA Drug Shortages
- Sodium Phosphate Injection (Updated - Currently in Shortage)
- Manual of Policies and Procedures (MAPP) 5015.7 Rev. 1 Environmental Assessments and Claims of Categorical Exclusion (PDF - 87KB)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario